Participant characteristics
| Participant characteristics | Median (range)/count |
| Age | 49 (30–75) years |
| Gender | |
| Male | 12 |
| Female | 28 |
| Race | |
| White | 34 |
| Others (Asian, Hispanic, biracial (Asian and Hispanic)) | 6 |
| Region in the USA | |
| West | 18 |
| Northeast | 8 |
| Midwest | 7 |
| South | 6 |
| Insurance | |
| Private | 34 |
| Medicare | 4 |
| Medicaid | 2 |
| Time since diagnosis | 19.5 (3–152) months |
| Cancer stage at time of interview | |
| IV | 38 |
| IIIb | 2 |
| Mutation | |
| ALK | 20 |
| EGFR | 14 |
| ROS1 | 6 |
ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; ROS1, c-ros oncogene 1.